Predicted probability of MC-TA-TMA by risk category among recipients of allogeneic HCT (N = 198)
| . | Cho criteria . | Jodele criteria . |
|---|---|---|
| Low risk (n = 153) | 5.2 (2.64-10.11) | 25.5 (19.2-33) |
| High risk (n = 45) | 77.8 (63.4-87.6) | 95.6 (83.9-98.9) |
| . | Cho criteria . | Jodele criteria . |
|---|---|---|
| Low risk (n = 153) | 5.2 (2.64-10.11) | 25.5 (19.2-33) |
| High risk (n = 45) | 77.8 (63.4-87.6) | 95.6 (83.9-98.9) |
Seven patients with graft failure were excluded from the analysis. Risk factors included ≥2 HCTs, active grade 3/4 aGVHD, or active bacterial, viral, or fungal infection. Data are predicted probability % (95% CI).
High risk, ≥1 risk factor; low risk, no risk factors.